Apiject

ApiJect is an swiftly expanding medical technology firm transforming how the globe receives injectable vaccination and medications – whether it's for epidemic prevention, branded and generic drugs, or global healthcare.ApiJect’s goal is to ensure injectable medication is secure and accessible for all. ApiJect is a founding member of The RAPID Consortium, which aims to provide America and its partners with 'surge capacity' to supply vaccines and medication in individual doses for injection – a capability that enhances defense against pandemics and other biological emergencies on a population scale.